Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Janusz H. S. Kabarowski, Kui Zhu, Lu Q. Le et al. · Science · 2001
Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.
Cited by 332 works. doi:10.1126/science.1061781
Authors
References
- Atherosclerosis
- Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.
- Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells.
- Sphingolipid metabolites: Members of a new class of lipid second messengers
- Bioactive Lysophospholipids and Their G Protein-Coupled Receptors
- Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
- Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.
- Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome
- Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation
- Isolation of Three Novel Human Genes Encoding G Protein-Coupled Receptors